Medicine
Meropenem 1 g/30 mL powder for injection
Meropenem 1 g/30 mL powder for injection is a generic prescription medicine for intravenous use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Meropenem
- Brand
- Sold under the generic name
- Strength
- 1 g/30 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 10 vials
- Manufacturers
- Amneal PharmaceuticalsSagent Pharmaceuticals3 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DH02 Meropenem
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 May 2016
- Identifiers
- RxCUI 1722934, 1722939DailyMed set ID e8848f4a-bca9-4978-b0a1-38483fd4d639, ca5f501c-6520-4d09-aae2-4f5db74d468f, a456013b-b20e-4b29-b2f9-06f18f1ea6bdNDC 25021-161, 68001-324, 70121-1453Application ANDA216424, ANDA205883
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, glass in 1 carton / 30 mL in 1 vial, glass | 70121-1453-7 | Amneal Pharmaceuticals | 9 May 2016 |
| 10 vial in 1 carton / 30 mL in 1 vial | 25021-161-30 | Sagent Pharmaceuticals | 1 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 June 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Meropenem
Clinical summary
Meropenem is a penem antibacterial indicated for the treatment of complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older requiring the full adult dose only), among other approved uses. MedsAcross supplies Meropenem for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MeropenemFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Meropenem and Sodium Chloride prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Meropenem 1 g/30 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.